pulmonary hypertension associated with pulmonary fibrosis clinical trial intelligence

Multicenter, Randomized, Open Label Trial to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

This clinical trial aimed to evaluate the safety and efficacy of oral treprostinil in subjects with pulmonary hypertension associated with pulmonary fibrosis. The study was designed as a multicenter, randomized, open-label trial involving at least 10 clinical trial centers and aimed to enroll 52 subjects over a 24-month period.

Matched by target_normalized: Pulmonary Hypertension associated with Pulmonary Fibrosis